About Cellis
Cellis is a biotechnology company developing macrophage-based cancer therapy for the treatment of solid tumors. We specialize in innovative cell-based oncology approaches, with a focus on overcoming resistance in difficult-to-treat cancers. Our proprietary platform, Macrophage Drug Conjugate (MDC), is based on the TRAIN mechanism, enabling targeted delivery of active compounds directly into the cytoplasm of cancer cells. This results in tumor cell death while simultaneously reshaping the tumor microenvironment to enhance anti-cancer immune responses. Cellis is advancing its pipeline toward first-in-human clinical trials, while building a strong intellectual property portfolio supported by PCT patent applications and ongoing filings.
- Founded
- 2016
- Employees
- 11 to 50
- Headquarters
- Switzerland
Leadership
The top of Cellis's org chart, with how many people report into each leader.
Robert Aleksandrowicz
Chief Executive Officer
Jobs at Cellis
No open positions right now. Explore more companies on TheJobsMap.